162 related articles for article (PubMed ID: 21896914)
41. Acyclic nucleoside phosphonates with 5-azacytosine base moiety substituted in C-6 position.
Krecmerová M; Masojídková M; Holý A
Bioorg Med Chem; 2010 Jan; 18(1):387-95. PubMed ID: 19914075
[TBL] [Abstract][Full Text] [Related]
42. Effects of the Delta67 complex of mutations in human immunodeficiency virus type 1 reverse transcriptase on nucleoside analog excision.
Boyer PL; Imamichi T; Sarafianos SG; Arnold E; Hughes SH
J Virol; 2004 Sep; 78(18):9987-97. PubMed ID: 15331732
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of nucleoside phosphonates and their analogs and prodrugs for inhibition of orthopoxvirus replication.
Keith KA; Hitchcock MJ; Lee WA; Holý A; Kern ER
Antimicrob Agents Chemother; 2003 Jul; 47(7):2193-8. PubMed ID: 12821467
[TBL] [Abstract][Full Text] [Related]
44. D- and L-2',3'-didehydro-2',3'-dideoxy-3'-fluoro-carbocyclic nucleosides: synthesis, anti-HIV activity and mechanism of resistance.
Wang J; Jin Y; Rapp KL; Schinazi RF; Chu CK
J Med Chem; 2007 Apr; 50(8):1828-39. PubMed ID: 17373782
[TBL] [Abstract][Full Text] [Related]
45. Activities of several classes of acyclic nucleoside phosphonates against camelpox virus replication in different cell culture models.
Duraffour S; Snoeck R; Krecmerová M; van Den Oord J; De Vos R; Holy A; Crance JM; Garin D; De Clercq E; Andrei G
Antimicrob Agents Chemother; 2007 Dec; 51(12):4410-9. PubMed ID: 17893157
[TBL] [Abstract][Full Text] [Related]
46. Synthesis and antiviral evaluation of alkoxyalkyl derivatives of 9-(S)-(3-hydroxy-2-phosphonomethoxypropyl)adenine against cytomegalovirus and orthopoxviruses.
Beadle JR; Wan WB; Ciesla SL; Keith KA; Hartline C; Kern ER; Hostetler KY
J Med Chem; 2006 Mar; 49(6):2010-5. PubMed ID: 16539388
[TBL] [Abstract][Full Text] [Related]
47. Amino Acid Ester Prodrugs of Nucleoside and Nucleotide Antivirals.
Krecmerova M
Mini Rev Med Chem; 2017; 17(10):818-833. PubMed ID: 28215138
[TBL] [Abstract][Full Text] [Related]
48. Synthesis and Anti-HIV Activity of Guanine Modified Fluorinated Acyclic Nucleoside Phosphonate Derivatives.
Luo M; Groaz E; De Jonghe S; Schols D; Herdewijn P
Chem Biodivers; 2019 Feb; 16(2):e1800532. PubMed ID: 30431702
[TBL] [Abstract][Full Text] [Related]
49. Activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) against guinea pig cytomegalovirus infection in cultured cells and in guinea pigs.
Li SB; Yang ZH; Feng JS; Fong CK; Lucia HL; Hsiung GD
Antiviral Res; 1990 May; 13(5):237-52. PubMed ID: 2168690
[TBL] [Abstract][Full Text] [Related]
50. Synthesis, anti-HIV activity, and resistance profile of thymidine phosphonomethoxy nucleosides and their bis-isopropyloxymethylcarbonyl (bisPOC) prodrugs.
Mackman RL; Zhang L; Prasad V; Boojamra CG; Douglas J; Grant D; Hui H; Kim CU; Laflamme G; Parrish J; Stoycheva AD; Swaminathan S; Wang K; Cihlar T
Bioorg Med Chem; 2007 Aug; 15(16):5519-28. PubMed ID: 17562366
[TBL] [Abstract][Full Text] [Related]
51. 6-[2-phosphonomethoxy)alkoxy]-2,4-diaminopyrimidines: a new class of acyclic pyrimidine nucleoside phosphonates with antiviral activity.
Balzarini J; Pannecouque C; Naesens L; Andrei G; Snoeck R; De Clercq E; Hocková D; Holý A
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1321-7. PubMed ID: 15571252
[TBL] [Abstract][Full Text] [Related]
52. Metabolic diversity and antiviral activities of acyclic nucleoside phosphonates.
Aduma P; Connelly MC; Srinivas RV; Fridland A
Mol Pharmacol; 1995 Apr; 47(4):816-22. PubMed ID: 7723743
[TBL] [Abstract][Full Text] [Related]
53. 1,2,4-Thiadiazole acyclic nucleoside phosphonates as inhibitors of cysteine dependent enzymes cathepsin K and GSK-3β.
Pomeislová A; Otmar M; Rubešová P; Benýšek J; Matoušová M; Mertlíková-Kaiserová H; Pohl R; Poštová Slavětínská L; Pomeisl K; Krečmerová M
Bioorg Med Chem; 2021 Feb; 32():115998. PubMed ID: 33440320
[TBL] [Abstract][Full Text] [Related]
54. Reshaping an Acyclic Nucleoside Phosphonate into a Selective Anti-hepatitis B Virus Compound.
Tan S; Groaz E; Kalkeri R; Ptak R; Korba BE; Herdewijn P
J Med Chem; 2022 Jul; 65(13):9396-9417. PubMed ID: 35754374
[TBL] [Abstract][Full Text] [Related]
55. Comparative inhibitory effects of nucleoside analogues on different clinical isolates of human cytomegalovirus in vitro.
Shigeta S; Konno K; Baba M; Yokota T; De Clercq E
J Infect Dis; 1991 Feb; 163(2):270-5. PubMed ID: 1846389
[TBL] [Abstract][Full Text] [Related]
56. Inhibition of the in vitro growth of Plasmodium falciparum by acyclic nucleoside phosphonates.
Smeijsters LJ; Franssen FF; Naesens L; de Vries E; Holý A; Balzarini J; de Clercq E; Overdulve JP
Int J Antimicrob Agents; 1999 Jun; 12(1):53-61. PubMed ID: 10389648
[TBL] [Abstract][Full Text] [Related]
57. A novel type of acyclic nucleoside phosphonates derived from 2-(phosphonomethoxy)propanoic acid.
Kaiser MM; Jansa P; Dračínský M; Janeba Z
Tetrahedron; 2012 May; 68(21):4003-4012. PubMed ID: 32287422
[TBL] [Abstract][Full Text] [Related]
58. (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, a potent and selective inhibitor of human cytomegalovirus replication.
Snoeck R; Sakuma T; De Clercq E; Rosenberg I; Holy A
Antimicrob Agents Chemother; 1988 Dec; 32(12):1839-44. PubMed ID: 2854454
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of herpesvirus replication by hexadecyloxypropyl esters of purine- and pyrimidine-based phosphonomethoxyethyl nucleoside phosphonates.
Prichard MN; Hartline CB; Harden EA; Daily SL; Beadle JR; Valiaeva N; Kern ER; Hostetler KY
Antimicrob Agents Chemother; 2008 Dec; 52(12):4326-30. PubMed ID: 18852272
[TBL] [Abstract][Full Text] [Related]
60. Amidate Prodrugs of Cyclic 9-(
Luo M; Groaz E; De Jonghe S; Snoeck R; Andrei G; Herdewijn P
ACS Med Chem Lett; 2018 Apr; 9(4):381-385. PubMed ID: 29670705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
